The Midas touch: Recombinant antibodies transforming diagnostic platforms

Area of Science:

• Biotechnology
• Immunology
• Medical Diagnostics

Background:

• Antibodies are vital for diagnostics due to specific antigen binding.
• Recombinant antibodies eliminate the need for animal immunization.
• Current diagnostic use of recombinant antibodies lags behind animal-derived ones.

Purpose of the Study:

• To review recombinant antibody development using in vitro display technologies.
• To highlight phage display and its derivative systems.
• To showcase the diagnostic potential of recombinant antibodies.

Main Methods:

• Focus on phage display technology for antibody presentation and selection.
• Exploration of derivative display systems: ribosome, yeast, bacterial, and mammalian cell display.
• Review of applications in recombinant antibody development.

Main Results:

• In vitro display technologies enable identification of specific antibodies.
• Phage display is a key technology for recombinant antibody generation.
• Derivative display systems offer diverse platforms for antibody development.

Conclusions:

• Recombinant antibodies hold significant promise for advancing diagnostic innovation.
• In vitro display technologies are crucial for developing these novel antibodies.
• Further development can bridge the gap between recombinant and animal-derived antibody applications.